Li, Daqiang

Publications

Sort by

Co-Author Network

selected publications

Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors. Nature communications. 2023 Academic Article GET IT
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance. Cell chemical biology. 2023 Academic Article GET IT
Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic Subunit. Journal of medicinal chemistry. 2023 Academic Article GET IT
Discovery of (S)-N-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6H)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug Candidate. Journal of medicinal chemistry. 2023 Academic Article
Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors. European journal of medicinal chemistry. 2018 Academic Article GET IT
Times cited: 2
Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors. European journal of medicinal chemistry. 2018 Academic Article GET IT
Times cited: 3
Development of Macrocyclic Peptides Containing Epoxyketone with Oral Availability as Proteasome Inhibitors. Journal of medicinal chemistry. 2018 Academic Article GET IT
Times cited: 7
Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors. European journal of medicinal chemistry. 2014 Academic Article GET IT
Times cited: 34